Remove solutions commercial-delivery learning-solutions
article thumbnail

Tapping into pharma’s growing opportunities in digital health

Pharmaceutical Technology

Pharma, which is already growing its role in delivering hybrid solutions combining therapies with diagnostic and smart solutions and devices, could play a significant role here, providing smart end-to-end solutions and data-related tools that transcend the immediate treatment. Breaking down the opportunities.

article thumbnail

RareMed Expands Concierge Patient Support Services to Complex Conditions

Drug Channels

Today’s guest post comes from Justin Smerker, VP of Business Development at RareMed Solutions. Justin introduces us to RareMed Solutions, a patient service provider that caters to patients with complex and rare diseases. This Feed is for personal non-commercial use only. d/b/a Drug Channels Institute.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EVERSANA and Intouch Group Join Forces, Adding The Premiere Digital-First Agency Network to the Market Leader in Next Generation Commercialization

Intouch Solutions

Together, the combined companies — with more than 40 global locations; 5,500 employees worldwide; and millions of dollars invested in digital transformation, data and analytics — are poised to deliver full-scale commercialization to pharmaceutical companies globally. Intouch shares our vision and hearty appetite for disruption.

article thumbnail

SLAS2024: Day One Highlights

Drug Discovery World

Software-as-a-service company Xavo is promoting its new AI-driven scheduling solution Copilot, created to optimise resource allocation and increase lab throughput. The collaboration is part of the Danaher Beacons program and aims to improve liver organoid technology as a drug toxicity screening solution for safeguarding patients.

article thumbnail

EVERSANA™ Unveils EVERSANA INTOUCH, a Next-Generation Agency Network

Intouch Solutions

Delivering Award-Winning Creative, Digital, and Global Market Ac c ess Solutions for Life Sciences. To learn more, visit eversanaintouch.com. With EVERSANA INTOUCH, EVERSANA is a $1 billion commercial services leader, poised to solve any global pricing, access, reimbursement, promotion, adherence, or product delivery challenge. ###.

article thumbnail

2024 predictions: Experts comment on AI, ML and automation

Drug Discovery World

Here, experts weigh in on the impact of artificial intelligence (AI), machine learning (ML) and automation in the sector. Updesh Dosanjh, Practice Leader for Pharmacovigilance Technology Solutions, IQVIA “In 2024, the traditional pain points of the pharmacovigilance (PV) space will not disappear.

Genome 139
article thumbnail

EVERSANA Completes Acquisition of Intouch Group

Intouch Solutions

Adds The Premiere Digital-First Agency Network to the Market Leader in Next G eneration Commercialization. With the added power of Intouch and millions more invested in data, analytics and digital transformation, we are reinventing commercial approaches for the benefit of our clients and their patients.”. CHICAGO and KANSAS CITY, Mo.